4//SEC Filing
GAROFALO ELIZABETH A. 4
Accession 0001415889-25-023592
CIK 0001070494other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 6:00 PM ET
Size
5.2 KB
Accession
0001415889-25-023592
Insider Transaction Report
Form 4
GAROFALO ELIZABETH A.
Director
Transactions
- Sale
Common Stock
2025-09-02$25.98/sh−1,600$41,560→ 25,382 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.97 to $25.991, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001826361
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 6:00 PM ET
- Size
- 5.2 KB